In conclusion, IFN-γ+ naïve γδT cells from TKI-treated CML patients played a role in shortening the time to reach DMR and in sustaining the duration on MR4.0. Here, IFNG is linked to chronic myelogenous leukemia, BCR-ABL1 positive.